BNGO – Bionano Genomics, Inc.
BNGO — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
11.99
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
-0.86
EPS Last/This Y
2.14
EPS This/Next Y
1.6
Price
1.22
Target Price
5
Analyst Recom
1
Performance Q
-25.31
Upside
-15,951.2%
Beta
1.67
Ticker: BNGO
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-27 | BNGO | 1.16 | N/A | N/A | 0 |
| 2026-03-30 | BNGO | 1.13 | N/A | N/A | 0 |
| 2026-03-31 | BNGO | 1.175 | N/A | N/A | 0 |
| 2026-04-01 | BNGO | 1.19 | N/A | N/A | 0 |
| 2026-04-02 | BNGO | 1.19 | N/A | N/A | 0 |
| 2026-04-06 | BNGO | 1.16 | N/A | N/A | 0 |
| 2026-04-08 | BNGO | 1.175 | N/A | N/A | 0 |
| 2026-04-09 | BNGO | 1.155 | N/A | N/A | 0 |
| 2026-04-13 | BNGO | 1.16 | N/A | N/A | 0 |
| 2026-04-14 | BNGO | 1.21 | N/A | N/A | 0 |
| 2026-04-15 | BNGO | 1.28 | N/A | N/A | 0 |
| 2026-04-17 | BNGO | 1.28 | N/A | N/A | 0 |
| 2026-04-20 | BNGO | 1.31 | N/A | N/A | 0 |
| 2026-04-21 | BNGO | 1.265 | N/A | N/A | 0 |
| 2026-04-23 | BNGO | 1.21 | N/A | N/A | 0 |
| 2026-04-24 | BNGO | 1.21 | N/A | N/A | 0 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-03-27 | BNGO | 1.15 | - | - | -7.72 |
| 2026-03-30 | BNGO | 1.12 | - | - | -2.53 |
| 2026-03-31 | BNGO | 1.18 | - | - | -2.53 |
| 2026-04-01 | BNGO | 1.19 | - | - | -2.53 |
| 2026-04-02 | BNGO | 1.19 | - | - | -2.53 |
| 2026-04-06 | BNGO | 1.15 | - | - | -2.53 |
| 2026-04-07 | BNGO | 1.16 | - | - | -2.53 |
| 2026-04-08 | BNGO | 1.17 | - | - | -2.53 |
| 2026-04-09 | BNGO | 1.15 | - | - | -2.53 |
| 2026-04-10 | BNGO | 1.13 | - | - | -2.71 |
| 2026-04-13 | BNGO | 1.17 | - | - | -2.71 |
| 2026-04-14 | BNGO | 1.19 | - | - | -2.71 |
| 2026-04-15 | BNGO | 1.27 | - | - | -2.71 |
| 2026-04-16 | BNGO | 1.26 | - | - | -2.71 |
| 2026-04-17 | BNGO | 1.28 | - | - | -2.71 |
| 2026-04-20 | BNGO | 1.31 | - | - | -2.71 |
| 2026-04-21 | BNGO | 1.26 | - | - | -2.71 |
| 2026-04-22 | BNGO | 1.25 | - | - | -2.71 |
| 2026-04-23 | BNGO | 1.22 | - | - | -2.71 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-03-27 | BNGO | 0.00 | 1.27 | 10.58 |
| 2026-03-30 | BNGO | 0.00 | 1.16 | 10.58 |
| 2026-03-31 | BNGO | 0.00 | 1.16 | 10.58 |
| 2026-04-01 | BNGO | 0.00 | 1.16 | 10.58 |
| 2026-04-02 | BNGO | 0.00 | 1.16 | 10.58 |
| 2026-04-06 | BNGO | 0.00 | 1.16 | 10.58 |
| 2026-04-07 | BNGO | 0.00 | 1.16 | 10.58 |
| 2026-04-08 | BNGO | 0.00 | 1.16 | 10.58 |
| 2026-04-09 | BNGO | 0.00 | 1.16 | 10.58 |
| 2026-04-10 | BNGO | 0.00 | 1.16 | 10.58 |
| 2026-04-13 | BNGO | 0.00 | 1.16 | 11.99 |
| 2026-04-14 | BNGO | 0.00 | 1.16 | 11.99 |
| 2026-04-15 | BNGO | 0.00 | 1.16 | 11.99 |
| 2026-04-16 | BNGO | 0.00 | 1.16 | 11.99 |
| 2026-04-17 | BNGO | 0.00 | 1.16 | 11.99 |
| 2026-04-20 | BNGO | 0.00 | 1.16 | 11.99 |
| 2026-04-21 | BNGO | 0.00 | 1.16 | 11.99 |
| 2026-04-22 | BNGO | 0.00 | 1.16 | 11.99 |
| 2026-04-23 | BNGO | 0.00 | 1.16 | 11.99 |
| 2026-04-24 | BNGO | 0.00 | 1.16 | 11.99 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.03
Avg. EPS Est. Current Quarter
-0.93
Avg. EPS Est. Next Quarter
-0.89
Insider Transactions
Institutional Transactions
1.16
Beta
1.67
Average Sales Estimate Current Quarter
7
Average Sales Estimate Next Quarter
7
Fair Value
Quality Score
37
Growth Score
40
Sentiment Score
29
Actual DrawDown %
100
Max Drawdown 5-Year %
-100
Target Price
5
P/E
Forward P/E
PEG
P/S
0.47
P/B
0.29
P/Free Cash Flow
EPS
-5.48
Average EPS Est. Cur. Y
-2.71
EPS Next Y. (Est.)
-1.11
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-92.59
Relative Volume
0.28
Return on Equity vs Sector %
-86.4
Return on Equity vs Industry %
-69
EPS 1 7Days Diff
-2.7
EPS 1 30Days Diff
-0.22
EBIT Estimation
◆
BNGO
Healthcare
$1.21
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
49.9
Range 1M
56.3%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
60%
EPS NY
57.3%
52W%
3.7%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+313.2% upside
Upside
+313.2%
Bionano Genomics, Inc.Sector: Healthcare
Industry: Medical Instruments & Supplies
Employees: 95
Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, China, Japan, South Korea, Singapore, India, and Australia. The company offers genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It also provides Saphyr and Stratys systems, which are sample-to-result solutions for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr and Stratys instruments, which are single-molecule imagers; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA; and Ionic purification system, which isolates and purifies nucleic acid molecules. In addition, the company offers Saphyr, Stratys, and Bionano compute servers; and VIA software, which offers one solution for solutions for cytogenetics and molecular genetics. Further, it provides testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; OGM-Dx HemeOne testing; OGM-Dx FSHD, a test for individuals suspected of having FSHD type 1; and OGM-Dx Postnatal Whole Genome SV and OGM-Dx Prenatal Whole Genome SV for comprehensive testing. Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California.
BNGO
Latest News
—
Caricamento notizie per BNGO…
stock quote shares BNGO – Bionano Genomics, Inc. Stock Price stock today
news today BNGO – Bionano Genomics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch BNGO – Bionano Genomics, Inc. yahoo finance google finance
stock history BNGO – Bionano Genomics, Inc. invest stock market
stock prices BNGO premarket after hours
ticker BNGO fair value insiders trading